Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer ; volume:20 ; number:1 ; day:12 ; month:3 ; year:2020 ; pages:1-8 ; date:12.2020
BMC cancer ; 20, Heft 1 (12.3.2020), 1-8, 12.2020
- Creator
-
Eoh, Kyung Jin
Kim, Hye Min
Lee, Jung-Yun
Kim, Sunghoon
Kim, Sang Wun
Kim, Young Tae
Nam, Eun Ji
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-6693-y
- URN
-
urn:nbn:de:101:1-2020060405181347442059
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eoh, Kyung Jin
- Kim, Hye Min
- Lee, Jung-Yun
- Kim, Sunghoon
- Kim, Sang Wun
- Kim, Young Tae
- Nam, Eun Ji
- SpringerLink (Online service)
Other Objects (12)
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Cost–utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
BRCA1 germline mutation and glioblastoma development: report of cases
Joint genotype inference with germline and somatic mutations
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Cost–utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
BRCA1 germline mutation and glioblastoma development: report of cases
Joint genotype inference with germline and somatic mutations
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Cost–utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain
High-grade serous ovarian cancer: the clone wars
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
BRCA1 germline mutation and glioblastoma development: report of cases
Joint genotype inference with germline and somatic mutations
First-Line Management of Advanced High-Grade Serous Ovarian Cancer